Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02486341Completed
Open-label trial of human insulin in diabetes mellitus (DM) (2 arms), sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoint: Mean Amplitude of Glycemic Excursions at 5 days. Started Mar 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02486341.